Remarkably, FACTin treatment of IPF hLF significantly reduced all hallmarks of fibrosis analyzed, thereby suggesting the use of FACTin for therapeutic approaches against IPF. The gene discussed is HLF; the disease is idiopathic pulmonary fibrosis.